1Folkman J,Angiogenesis:an organizing principle for drug discovery?[J].Nat Rev Drug Diseov,2007,6(4):273-286.
2Foss B,Bruserud O,Platelet functions and clinical effects in acute myelngenoas leukemia[J].Thromb Haemost,2008,99(1):27-37.
3Schaffner A,Rhyn P,Regulated expression of platelet factor 4 in human monocytes-role of PARS as a quantitatively important monocyte activation pathway[J].Leukoc,2005,78(1):202-209.
4Zhang X,Chen L,Bancroft D,et al,Crystal structure of recombinant human platelet factor 4[J].Biochemistry,1994,33 (2):8361-8366.
5Modi WS,Chen ZQ,Localization of the human CXC chemokine subfamily on the long arm of chromosome 4 using radiation hybrid[J].Genomics,1998,47(1):136-139.
6Hamlett I,Draper J,Strouboulis J,et al,Characterization of megakaryocyte GATA1-interacting proteias:the corepressor ETO2 and GATA1 interact to regulate terminal megakaryocyte maturation[J].Blood,2008,112(7):2738-2749.
7Hansell P,Malone TE,Borgstrom P,et al,Selective binding of platelet factor 4 to regions of active angiogenesis in vivo[J].Am J Physiol,1995,269 (3):H829-H836.
8Gengrinovitch S,Greenberg SM,Cohen J,et al,Platelet factor-4 inhibited the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanism[J].J Biol Chem,1995,270 (25):150-159.
9Sulpice E,Contreres JO,Lacour J,et al,Platelet factor 4 disrupt the intracellular signaling cascade induced by vascular endothelial growth factor by both KDR dependent and independent mechanisms[J].Eu J Biochem,2004,271 (16):3310-3318.
10Sulpice E,Bryckaert M,Lacour J,et al,Platelet factor 4,inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by phosphatidylinositol 3-kinase pathway[J].Blood,2002,100 (9):3087-3094.
